Author Interviews, Cost of Health Care, Global Health, Lancet / 01.07.2014
Slowdown In US Health Care Costs Largely Due to Flat Physician Reimbursement, Use of Generic Drugs
MedicalResearch.com Interview with:
M Luca Lorenzoni
OECD Organisation for Economic Co-operation and Development
Health Accounts, Asian Health and Social Policy Outreach
ELS/Health Division
MedicalResearch: What are the main findings of the study?
Answer:
- The United States is an outlier in the scenery of OECD as it ranks first for health care expenditure, but last for coverage.
- The slowdown in US health care spending during the past decade brought the growth rate closer to that of other high-spending countries -Canada, France, Germany, the Netherlands and Switzerland- at around 1%. Previously in 2002, the US's health expenditure growth was around 7%, much higher than the approximate 3% which was the average for the other countries examined in the study
- Higher health-sector prices (e.g., hospital care and prescription drugs) are thought to be the main driver of expenditure differences between the US and other high-spending countries, and recent price dynamics largely explain declines in health expenditure growth. (more…)